Glen Eagle Advisors, LLC Bristol Myers Squibb CO Transaction History
Glen Eagle Advisors, LLC
- $604 Billion
- Q1 2025
A detailed history of Glen Eagle Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 10,190 shares of BMY stock, worth $474,344. This represents 0.1% of its overall portfolio holdings.
Number of Shares
10,190
Previous 3,429
197.17%
Holding current value
$474,344
Previous $194 Million
220.42%
% of portfolio
0.1%
Previous 0.03%
Shares
33 transactions
Others Institutions Holding BMY
# of Institutions
2,665Shares Held
1.6BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.41 Billion0.24% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...